吉林敖东药业集团股份有限公司关于控股子公司获得药品注册证书的自愿性信息披露公告

Core Viewpoint - Jilin Aodong Pharmaceutical Group Co., Ltd. announced that its subsidiary, Yanji Pharmaceutical, received a drug registration certificate for Terbutaline Sulfate Nebuliser Solution, enhancing the company's product portfolio and core competitiveness [1][3]. Drug Registration Details - The drug is classified as a chemical drug of category 4, with a specification of 2ml:5mg and a shelf life of 24 months [1][2]. - The drug is indicated for the relief of bronchial asthma, chronic bronchitis, emphysema, and other lung diseases associated with bronchospasm [3]. Impact on the Company - The acquisition of the drug registration certificate is expected to improve the company's product structure and diversify its product offerings, creating favorable conditions for steady development [3]. - The company plans to comply with relevant laws and regulations while conducting production and sales of the new product, although the sales performance may be influenced by market conditions [3].